These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1692572)

  • 41. N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.
    Jiang S; Lu H; Liu S; Zhao Q; He Y; Debnath AK
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4349-59. PubMed ID: 15504864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A sulphated fucan from the Laminaria abyssalis inhibits the human T cell lymphotropic virus type 1-induced syncytium formation in HeLa cells.
    Romanos MT; Andrada-Serpa MJ; Mourão PA; Yoneshigue-Valentin Y; Costa SS; Pereira MS; Miranda MM; Gonçalves JL; Wigg MD
    Antivir Chem Chemother; 2002 Jul; 13(4):219-21. PubMed ID: 12495209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of serotonin and melanin on in vitro HIV-1 infection.
    Sidibe S; Saal F; Rhodes-Feuillette A; Lagaye S; Pelicano L; Canivet M; Peries J; Dianoux L
    J Biol Regul Homeost Agents; 1996; 10(1):19-24. PubMed ID: 9049777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells.
    Schols D; Baba M; Pauwels R; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):10-5. PubMed ID: 2465402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of entry of HIV into cells by poly(A).poly(U).
    Krust B; Callebaut C; Hovanessian AG
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1087-90. PubMed ID: 8312051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral agents with activity against human retroviruses.
    Tochikura TS; Nakashima H; Yamamoto N
    J Acquir Immune Defic Syndr (1988); 1989; 2(5):441-7. PubMed ID: 2477523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
    Mohan P; Singh R; Baba M
    Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil.
    Ferraro GA; Mello MA; Sutmöller F; Van Weyenbergh J; Shindo N; Galvão-Castro B; Bou-Habib DC;
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1241-7. PubMed ID: 11559423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Misinterpretation in virus clearance studies of biological products due to an uncommon discrepancy between cytopathic effects and infectivity of human immunodeficiency virus (HIV).
    Urayama T; Cameron R; Sato T; Yunoki M; Ikuta K
    Biologicals; 2013 Mar; 41(2):125-7. PubMed ID: 23131459
    [No Abstract]   [Full Text] [Related]  

  • 51. Blocking of HIV-1 infection, but not HIV-1-induced syncytium formation, by a CD4 peptide derivative partly corresponding to an immunoglobulin CDR3.
    Ohki K; Kimura T; Ohmura K; Kato S; Ikuta K
    AIDS; 1990 Nov; 4(11):1160-1. PubMed ID: 2282193
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of sulfated carbohydrates on the accessibility of CD4 and other CD molecules on the cell surface and implications for human immunodeficiency virus infection.
    Thiele B; Braig HR; Ehm I; Kunze R; Ruf B
    Eur J Immunol; 1989 Jun; 19(6):1161-4. PubMed ID: 2473910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
    Jansen RW; Molema G; Pauwels R; Schols D; De Clercq E; Meijer DK
    Mol Pharmacol; 1991 Jun; 39(6):818-23. PubMed ID: 2051994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
    Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
    Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes.
    de Mareuil J; Mabrouk K; Doria E; Moulard M; de Chasteigner S; Oughideni R; van Rietschoten J; Rochat H; De Waard M; Sabatier JM
    Antiviral Res; 2002 Jun; 54(3):175-88. PubMed ID: 12062390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells.
    Tang SB; Levy JA
    J Virol Methods; 1991 Jun; 33(1-2):39-46. PubMed ID: 1682337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of some polysulphated polysaccharides on hyaluronate (HA) synthesis by human synovial fibroblasts.
    Smith MM; Ghosh P
    Agents Actions Suppl; 1986; 18():55-62. PubMed ID: 2425605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-human immunodeficiency virus type 1 activity of sulfated monosaccharides: comparison with sulfated polysaccharides and other polyions.
    Bagasra O; Whittle P; Heins B; Pomerantz RJ
    J Infect Dis; 1991 Dec; 164(6):1082-90. PubMed ID: 1720153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxicity and activity of purified trichosanthin.
    Ferrari P; Trabaud MA; Rommain M; Mandine E; Zalisz R; Desgranges C; Smets P
    AIDS; 1991 Jul; 5(7):865-70. PubMed ID: 1892592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.
    Ito M; Baba M; Sato A; Pauwels R; De Clercq E; Shigeta S
    Antiviral Res; 1987 Jul; 7(6):361-7. PubMed ID: 2445284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.